Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India
Pharmacovigilance Programme of India (PvPI) was established to promote patient safety by the Ministry of Health and Family Welfare, Government of India in July 2010. It covers various medical hospitals/institutes and National Health Programmes across the country. India is coordinating with various n...
Main Authors: | Pramod Kumar, Ismeet Kaur, Vivekanandan Kalaiselvan, Abhishank Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Indian Journal of Anaesthesia |
Subjects: | |
Online Access: | http://www.ijaweb.org/article.asp?issn=0019-5049;year=2017;volume=61;issue=7;spage=534;epage=537;aulast=Kumar |
Similar Items
-
Awareness among tertiary care doctors about Pharmacovigilance Programme of India: Do endocrinologists differ from others?
by: Pramod Kumar Sharma, et al.
Published: (2016-01-01) -
Pivotal role of Pharmacovigilance Programme of India in containment of antimicrobial resistance in India
by: Vijit Agrawal, et al.
Published: (2019-01-01) -
Pharmacovigilance Programme of India
by: Duvvuru Ashok Kumar, et al.
Published: (2015-01-01) -
Drug safety alerts of pharmacovigilance programme of India: A scope for targeted spontaneous reporting in India
by: Prasad Thota, et al.
Published: (2018-01-01) -
Reporting of adverse drug reactions due to cardiovascular drugs in India: A national duty
by: Vivekanandan Kalaiselvan
Published: (2015-11-01)